IRVINE, Calif., June 17 /PRNewswire/ -- NeoMend, Inc. today announced that its ProGEL(TM) Surgical Sealant has received a recommendation for approval from the U.S. Food and Drug Administration's (FDA) Anesthesiology andRespiratory Therapy Devices Advisory Panel.The panel's recommendation will be considered by the FDA during completion of its review of the Premarket Approval (PMA) for ProGEL. The panel's recommendation for FDA approval was conditioned principally on NeoMend conducting a post approval study to gather more safety data.
While Neomend products are for sealing, and anti-adhesion they also are conducting trials of a vascular closure product ProGEL-VS
While Neomend products are for sealing, and anti-adhesion they also are conducting trials of a vascular closure product ProGEL-VS
